Lataa...
Lifetime cost effectiveness of simvastatin in a range of risk groups and age groups derived from a randomised trial of 20 536 people
Objectives To evaluate the cost effectiveness of 40 mg simvastatin daily continued for life in people of different ages with differing risks of vascular disease. Design A model developed from a randomised trial was used to estimate lifetime risks of vascular events and costs of treatment and hospita...
Tallennettuna:
| Aineistotyyppi: | Artigo |
|---|---|
| Kieli: | Inglês |
| Julkaistu: |
BMJ Publishing Group Ltd.
2006
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1676106/ https://ncbi.nlm.nih.gov/pubmed/17098764 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmj.38993.731725.BE |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|